Analysis of the rational use of sunitinib (Sutent) and the precautions for taking it

Sunitinib (Sunitinib) is a multi-target tyrosine kinase inhibitor that mainly acts on vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR), KIT receptor, FLT3 and other targets, which can inhibit tumor angiogenesis and prevent tumor cell proliferation. The drug is widely used in the treatment of advanced renal cell carcinoma, gastrointestinal stromal tumors (GIST) and pancreatic neuroendocrine tumors (pNET). It is one of the commonly used oral targeted drugs in clinical practice. Due to its long course of treatment and the reliance on standardized efficacy, patients need to strictly follow reasonable medication methods and precautions during use to ensure the therapeutic effect and reduce the risk of adverse reactions.

1. Standard dosage of sunitinib

The common recommended dose of sunitinib is 50mg, once a day, taken continuously for 4 weeks and then stopped for 2 weeks, forming a 6 weeks of treatment. In some indications, doctors may also adjust the dose based on the condition and tolerance, such as a daily 37.5 mg continuous dosage regimen. When taking medicine, you should try to choose a fixed time and swallow it on time every day, and avoid changing the dosage or medication cycle at will. The medicine should be swallowed whole. Chewing, breaking or dissolving is not recommended to ensure the release and absorption of the medicine in the body.

In addition, patients need to undergo a comprehensive assessment before treatment, including blood routine, liver and kidney function, electrocardiogram and blood pressure measurement, so that doctors can formulate a reasonable plan based on individual conditions. If adverse reactions are intolerable during treatment, the doctor may recommend reduction in dosage (such as 37.5mg or 25mg/day) or temporary discontinuation of the drug, rather than the patient handling it on his own.

2. Monitoring and follow-up during medication

During sunitinib treatment, dynamic monitoring is particularly critical. First of all, patients need to undergo regular blood routine tests to prevent hematological adverse reactions such as leukopenia and thrombocytopenia. Secondly, attention should be paid to liver function and renal function, because drug metabolism is mainly through the liver, and damage to liver function may aggravate drug toxicity.

In addition, sunitinib may cause cardiotoxicity, such as decreased left ventricular ejection fraction or heart failure, and some patients may even experienceQT interval prolongation. Therefore, cardiac function should be monitored before and during treatment, and echocardiography and electrocardiography should be performed if necessary. For patients with hypertension, dynamic monitoring of blood pressure is also very important, because drugs can induce or aggravate hypertension.

In terms of tumor efficacy evaluation, patients usually conduct CT or MRI examination after 2-3 cycles to determine the efficacy, and adjust the treatment plan based on imaging changes and clinical symptoms.

3. Precautions when taking medication

1.Dietary aspects

Sunitinib can be taken with food or on an empty stomach, but it is necessary to avoid taking it with grapefruit or grapefruit juice at the same time, because it can inhibit the CYP3A4 enzyme, leading to an increase in blood concentration and an increased risk of toxic side effects. Patients should maintain a balanced diet and supplement high-protein, vitamin-rich foods to help the body recover.

2.Drug interactions

Sunitinib is mainly metabolized by CYP3A4. The combined use of CYP3A4 strong inhibitors (such as ketoconazole, clarithromycin) will increase the blood concentration, while CYP3A4 inducers (such as rifampin, phenytoin) will reduce the drug concentration and affect the efficacy. Therefore, if patients need to combine other drugs, they should inform their doctor in advance, and professionals will judge whether to adjust the dosage or change drugs.

3.Contraindications in pregnancy and breastfeeding

Sunitinib may cause serious harm to the fetus, so it is contraindicated in pregnant women. Women of childbearing age must use effective contraceptive measures during treatment and for a period of time after stopping the drug. Breastfeeding women should also avoid taking medication to prevent the medication from affecting their baby's health through milk.

4.Side Effect Treatment

Common side effects of sunitinib include fatigue, nausea, hand-foot syndrome, oral mucositis, skin pigment changes, thyroid dysfunction, etc. When mild adverse reactions occur, they can be improved through symptomatic treatment, such as using moisturizing cream to relieve hand and foot reactions, and using oral care solutions to prevent oral ulcers. If the side effects are serious, you need to seek medical treatment in time, and the doctor will decide whether to reduce the dosage or discontinue the medication.

4. Patient self-management and long-term medication recommendations

The treatment course of sunitinib is often long, and patients must establish awareness of long-term standardized medication. Medical advice should be strictly followed and no medication should be stopped or the dose increased on your own to avoid disease progression or an increase in side effects. In daily life, patients can create a medication record form or use reminder software to ensure that no medication is missed. If you accidentally miss a dose, you should take it as soon as possible on the day you remember. However, if it is close to the time of the next dose, skip that time and do not double the dose.

At the same time, patients need to maintain a good lifestyle, such as regular work and rest, moderate exercise, and avoidance of tobacco and alcohol to help enhance body tolerance. Psychologically, patients undergoing long-term targeted therapy may experience anxiety or depression, and it is recommended to seek family support or professional psychological counseling.

Long-term use of sunitinib requires caution Resistance issues. Once imaging examinations indicate tumor progression, you should communicate with your doctor as soon as possible to evaluate whether to switch to other targeted drugs or combination therapy.

Sunitinib, as a multi-target tyrosine kinase inhibitor, plays an important role in the treatment of various solid tumors. Rational medication use includes taking medication on time and in the right amount, following the recommended course of treatment, combined with regular monitoring of blood routine, liver, kidney and heart functions. Medication precautions cover aspects such as diet, drug interactions, pregnancy contraindications, and side effects management. Through scientific and standardized self-management and long-term follow-up, the efficacy of sunitinib can be maximized while reducing the risk of adverse reactions, thus bringing better survival benefits and quality of life to patients.

Reference materials:https://www.drugs.com/